The frustration of diabetic patients to constantly prick their fingers to monitor their blood sugar levels might come to an end. The Juvenile Diabetes Research Foundation developed an ‘artificial pancreas’ that could allow diabetics to control their blood sugar automatically.
The device is part implant, part worn device consisting of an insulin pump, a continuous glucose monitor, and advanced control software. It automatically monitors blood sugar and vary insulin level doses accordingly getting rid of the patient’s need for constant calculation and adjustments.
Diabetes is one of the most widespread and costly diseases in the developed world. Linked to the growing obesity epidemic in the US, about 26 million or 8% of the country has the condition, and its the 7th leading cause of death in the nation. If this technology works it will get rid of many pains and wrongly administered insulin doses to diabetic patients: the process will become an automatic action rather than a forced one. The promising project has yet to go through several clinical trials before it can be commercialized.
JDRF (formerly known as the Juvenile Diabetes Research Foundation) is a major charitable 501(c)(3) organization dedicated to funding type 1 diabetes research (T1D).